Immunomedics Broke Exit Deal With Founder, Chancery Told
An attorney for the scientist-founder and former chairman of a company acquired last year by Gilead Sciences for $21 billion told a Delaware vice chancellor on Friday that Immunomedics Inc. was...To view the full article, register now.
Already a subscriber? Click here to view full article